NatWest Group’s Pfizer PFE Stock Holding History

NatWest Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-46,329	Closed	-$1.44M	–	74
2020 Q1	$1.44M	Sell	46,329 -1,829	-4%	-$62.3K	0.4%	42
2019 Q4	$1.79M	Hold	48,158	–	–	0.38%	45
2019 Q3	$1.64M	Hold	48,158	–	–	0.4%	40
2019 Q2	$1.98M	Buy	+48,158	New	+$1.91M	0.36%	35
2018 Q2	–	Sell	-6,561	Closed	-$221K	–	81
2018 Q1	$221K	Hold	6,561	–	–	0.05%	80
2017 Q4	$225K	Sell	6,561 -3,373	-34%	-$115K	0.05%	75
2017 Q3	$336K	Hold	9,934	–	–	0.08%	83
2017 Q2	$317K	Sell	9,934 -949	-9%	-$29.9K	0.07%	87
2017 Q1	$353K	Hold	10,883	–	–	0.08%	88
2016 Q4	$335K	Buy	10,883 +692	+7%	+$21.1K	0.09%	93
2016 Q3	$327K	Sell	10,191 -72,467	-88%	-$2.42M	0.08%	104
2016 Q2	$2.76M	Sell	82,658 -1,370	-2%	-$43.7K	0.7%	38
2016 Q1	$2.36M	Buy	84,028 +75,511	+887%	+$2.16M	0.53%	42
2015 Q4	$261K	Sell	8,517 -409,799	-98%	-$12.9M	0.05%	107
2015 Q3	$12.5M	Buy	418,316 +53,019	+15%	+$1.7M	0.28%	40
2015 Q2	$11.6M	Sell	365,297 -12,704	-3%	-$414K	0.15%	51
2015 Q1	$12.5M	Sell	378,001 -6,154	-2%	-$196K	0.16%	44
2014 Q4	$11.4M	Sell	384,155 -111,486	-22%	-$3.2M	0.1%	57
2014 Q3	$13.9M	Buy	495,641 +2,020	+0.4%	+$56.7K	0.12%	43
2014 Q2	$13.9M	Sell	493,621 -12,554	-2%	-$358K	0.58%	45
2014 Q1	$15.4M	Sell	506,175 -704,949	-58%	-$21M	0.68%	37
2013 Q4	$35.2M	Buy	1,211,124 +241,299	+25%	+$7.02M	0.89%	21
2013 Q3	$26.4M	Sell	969,825 -1,933,529	-67%	-$52.6M	0.77%	24
2013 Q2	$77.2M	Buy	+2,903,354	New	+$80.2M	1.1%	12

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NatWest Group's PFE Position: Q2 2020 in Review

NatWest Group sold out of Pfizer (PFE) in Q2 2020, closing a stake of 46,329 shares — an estimated $1.44M sold.

NatWest Group first reported a position in PFE in Q2 2013 and held it in 24 quarters. The position peaked at $77.2M in Q2 2013. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

NatWest Group reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
NatWest Group sold 46,329 Pfizer shares in Q2 2020, an estimated $1.44M.
NatWest Group first reported a position in Pfizer in Q2 2013 and held it in 24 quarters.
NatWest Group's Pfizer position peaked at $77.2M in Q2 2013.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on NatWest Group's 13F filing for Q2 2020, filed 16 Jul 2020.